New target developed to improve production of important medical radioisotope

ANSTO has made progress on a more cost-effective way to produce the medical radioisotope molybdenum-99 (Mo-99), with less enrichment of uranium-235 (U-235) and producing less waste. ANSTO supplies the Australian medical community with molybdenum-99, the precursor of technetium 99m, which is one of the most commonly used nuclear diagnostic imaging agents for the diagnosis of cancer, heart disease, organ structure and function, and supports other medical applications.


2 w.
Science
ID: -6358730484803905258


Similar News expand_more


Military
Science
Education
Technology
Technology
Technology
Technology
Technology
Military
Science
Science
Technology
Science
Technology
Technology
Science
Technology
Technology
Military
Space
Education
Technology
Science
Science
Weather
Space
Military
Technology
Technology
Culture
Technology
Technology
Military
Science
Science
Science
Science
Technology
Technology
Science
Technology
Politics
Science
Science
Crime
Technology
Technology
Technology
Technology
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down